Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
0.0071
+0.0010 (16.39%)
Jan 21, 2026, 4:00 PM EST
Curative Biotechnology Market Cap
Curative Biotechnology has a market cap or net worth of $7.51 million as of January 23, 2026. Its market cap has decreased by -36.18% in one year.
Market Cap
7.51M
Enterprise Value
10.96M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since February 22, 2008, Curative Biotechnology's market cap has decreased from 22.36M to 7.51M, a decrease of -66.41%. That is a compound annual growth rate of -5.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 7.47M | 28.93% |
| Dec 31, 2025 | 5.79M | -50.77% |
| Dec 31, 2024 | 11.77M | -12.66% |
| Dec 29, 2023 | 13.47M | 17.84% |
| Dec 30, 2022 | 11.43M | -61.12% |
| Dec 31, 2021 | 29.41M | 201.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TRON Group | 11.06M |
| AccuStem Sciences | 10.45M |
| Biomind Labs | 8.84M |
| NKGen Biotech | 7.84M |
| Synlogic | 6.68M |
| Brainstorm Cell Therapeutics | 6.51M |
| Clearside Biomedical | 6.02M |
| Bioxytran | 5.95M |